Garvan Institute of Medical Research

pancreatic cancer cells

Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of an aggressive form of pancreatic cancer.

Peter Wejbora, Seam Smith, David Thomas, Ute Roessner, Paul Jeans, Stuart Knight. jpg

UNSW Sydney’s Centre for Molecular Oncology will partner with not-for-profit cancer genomics leader Omico to deliver the national precision oncology program PrOSPeCT.

Image of pluripotent stem cells

A new technique developed at the Garvan Institute of Medical Research and UNSW Sydney could make stem cell studies up to 100 times more efficient.

Woman sitting on couch eating chips, burger and drinking Coke

A new study in mice shows that stress can override natural satiety cues and drive cravings for sweet foods.

A person clutches their back as a doctor points to a model of a spine

Fifteen projects have received funding from the Australian Government's Medical Research Future Fund.

Obese man prepares Ozempic pen. Semaglutide treatment for type 2 diabetes.

Stronger advertising regulations and other weight loss drug options are needed, UNSW Sydney experts say.

John Pimanda

Professor John Pimanda receives the new Translational Program Grant for his team’s work with acute myeloid leukaemia.

COVID vaccination

A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.

Person receiving vaccination

Clinical trial results for a new melanoma vaccine are promising, but UNSW Sydney experts say key questions still need to be answered.

NRMRC Ideas Grants

20 UNSW academics receive NHMRC Ideas Grants for research in medicine and health, and science.

Pages